These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 23306064)

  • 41. Predicting functional decline in behavioural variant frontotemporal dementia.
    Josephs KA; Whitwell JL; Weigand SD; Senjem ML; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Jack CR; Petersen RC
    Brain; 2011 Feb; 134(Pt 2):432-48. PubMed ID: 21252111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Damage to left frontal regulatory circuits produces greater positive emotional reactivity in frontotemporal dementia.
    Sturm VE; Yokoyama JS; Eckart JA; Zakrzewski J; Rosen HJ; Miller BL; Seeley WW; Levenson RW
    Cortex; 2015 Mar; 64():55-67. PubMed ID: 25461707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional brain atrophy and impaired decision making on the balloon analog risk task in behavioral variant frontotemporal dementia.
    Strenziok M; Pulaski S; Krueger F; Zamboni G; Clawson D; Grafman J
    Cogn Behav Neurol; 2011 Jun; 24(2):59-67. PubMed ID: 21697710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving response inhibition systems in frontotemporal dementia with citalopram.
    Hughes LE; Rittman T; Regenthal R; Robbins TW; Rowe JB
    Brain; 2015 Jul; 138(Pt 7):1961-75. PubMed ID: 26001387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.
    Lee GJ; Lu PH; Mather MJ; Shapira J; Jimenez E; Leow AD; Thompson PM; Mendez MF
    J Alzheimers Dis; 2014; 41(3):793-800. PubMed ID: 24685626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease.
    Garcia-Diaz AI; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Vendrell P; Bargallo N; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1405-10. PubMed ID: 25457818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regional patterns of brain tissue loss associated with depression in Parkinson disease.
    Kostić VS; Agosta F; Petrović I; Galantucci S; Spica V; Jecmenica-Lukic M; Filippi M
    Neurology; 2010 Sep; 75(10):857-63. PubMed ID: 20686125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.
    Gama RL; Bruin VM; Távora DG; Duran FL; Bittencourt L; Tufik S
    Brain Cogn; 2014 Jun; 87():97-103. PubMed ID: 24732953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired reproduction of second but not millisecond time intervals in Parkinson's disease.
    Koch G; Costa A; Brusa L; Peppe A; Gatto I; Torriero S; Gerfo EL; Salerno S; Oliveri M; Carlesimo GA; Caltagirone C
    Neuropsychologia; 2008 Apr; 46(5):1305-13. PubMed ID: 18215403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Weintraub D; Antonini A
    Mov Disord; 2015 Apr; 30(5):688-95. PubMed ID: 25649923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia.
    Compta Y; Ibarretxe-Bilbao N; Pereira JB; Junqué C; Bargalló N; Tolosa E; Valldeoriola F; Muñoz E; Camara A; Buongiorno M; Martí MJ
    Parkinsonism Relat Disord; 2012 Sep; 18(8):941-7. PubMed ID: 22595621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychopathy as a disorder of the moral brain: fronto-temporo-limbic grey matter reductions demonstrated by voxel-based morphometry.
    de Oliveira-Souza R; Hare RD; Bramati IE; Garrido GJ; Azevedo Ignácio F; Tovar-Moll F; Moll J
    Neuroimage; 2008 Apr; 40(3):1202-13. PubMed ID: 18289882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.